<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7489051\results\search\drug\results.xml">
  <result pre="clinical trials along with umifenovir (also named Arbidol) and ribavirin." exact="Chloroquine" post="(CQ), a widely used antimalarial and immunomodulatory drug, showed"/>
  <result pre="These findings led to 15 clinical trials of CQ or" exact="hydroxychloroquine" post="(HCQ) in China to test their efficacy and safety"/>
  <result pre="the Guidelines for the Diagnosis and Treatment of COVID-19, glucocorticoid" exact="methylprednisolone" post="was prudently recommended to treat severe patients at a"/>
  <result pre="(200 mg/50 mg per capsule, 2 capsules each time, BID);" exact="ribavirin" post="(500 mg by venoclysis per time, BID, combination treatment"/>
  <result pre="IL-6 level. Â (8) Other therapies, including low dosage of" exact="methylprednisolone" post="(â‰¤1â€&quot;2 mg kgâ€&quot;1 dayâ€&quot;1) and intestinal microecological regulators. aBID,"/>
  <result pre="of action inÂ vitro/inÂ vivo effect CoV type ref 1" exact="Chloroquine" post="(CQ) IncreasesÂ endosomalÂ pH; disrupts intracellular trafficking and viral"/>
  <result pre="and the duration of fever. SARS-CoV-2 Huang et al.39 2" exact="Hydroxychloroquine" post="(HCQ) The same as CQ. In vitro IC50: 0.72"/>
  <result pre="relief for pyrexia and cough. SARS-CoV-2 Chen et al.64 5" exact="Ribavirin" post="Inhibits viral RNA synthesis and mRNA capping. In vitro"/>
  <result pre="In vitro The cytopathic effect of SARS-CoV was inhibited by" exact="ribavirin" post="at 50 Î¼g/mL SARS-CoV Chu et al.66 IC50: 109.5"/>
  <result pre="vitro The cytopathic effect of the SARS-CoV was inhibited by" exact="lopinavir" post="at 4 Î¼g/mL. SARS-CoV Chu et al.66 IC50: 17.1"/>
  <result pre="&amp;gt;37.6 Î¼M; SI: 5.7 HCoV-229E Lopinavir/ritonavir A fixed dose of" exact="ritonavir" post="was used to increase lopinavir half-life through the inhibition"/>
  <result pre="Lopinavir/ritonavir A fixed dose of ritonavir was used to increase" exact="lopinavir" post="half-life through the inhibition of cytochrome P450. Randomized, controlled,"/>
  <result pre="3.1 14 Tingenone 9.9 4.0 15 Iguesterin 2.6 0.8 16" exact="Hesperetin" post="Isatis indigotica 8.3 NT - Lin et al.93 17"/>
  <result pre="produce IFNs. 2.12 &amp;gt;35.5 &amp;gt;16.7 SARS-CoV-2 WangÂ etÂ al.16 49" exact="Nafamostat" post="Inhibits S protein-mediated membrane fusion. 22.5 &amp;gt;100 &amp;gt;4.4 50"/>
  <result pre="Nafamostat Inhibits S protein-mediated membrane fusion. 22.5 &amp;gt;100 &amp;gt;4.4 50" exact="Penciclovir" post="Inhibits RdRp. 95.9 &amp;gt;400 &amp;gt;4.2 aNT, not tested. Table"/>
  <result pre="ipecacuanha 0.30 2.69 9.0 HCoV-OC43 1.43 3.63 2.5 HCoV-NL63 63" exact="Mycophenolate mofetil" post="Derivative 1.58 3.43 2.2 HCoV-OC43 0.23 3.01 13 HCoV-NL63"/>
  <result pre="Fangchinoline 0.91 12.4 11 69 Cepharanthine 0.72 10.5 13 70" exact="Reserpine" post="Rauwolfia serpentina 3.4 25 7.3 SARS-CoV Wu et al.67"/>
  <result pre="MERS-CoV, in cultured cells and mouse models.49 It is an" exact="adenosine" post="analog that is incorporated into nascent viral RNA chains,"/>
  <result pre="clinical studies. 3.1.2 Other Effective CoV Inhibitors Another guanine derivative," exact="ribavirin" post="(4), approved for treating hepatitis C virus (HCV) and"/>
  <result pre="to block the SARS-CoV 3CLpro67 and is usually combined with" exact="ritonavir" post="(6) to increase the half-life of lopinavir by inhibiting"/>
  <result pre="usually combined with ritonavir (6) to increase the half-life of" exact="lopinavir" post="by inhibiting cytochrome P450.68 On January 18, 2020, a"/>
  <result pre="used to treat chronic pancreatitis. Zhou et al. reported that" exact="camostat" post="was effective in protecting mice from a lethal infection"/>
  <result pre="SARS-CoV-2 entry into mouse lung cells.78 These findings suggest that" exact="camostat" post="may be a valuable therapeutic against COVID-19. 3.2 Potential"/>
  <result pre="evaluated for their anti-SARS-CoV 3CLpro activities. Among them, the flavonoid" exact="hesperetin" post="(16, IC50 = 8.3 Î¼M) showed the highest inhibitory"/>
  <result pre="PLpro (IC50, 3.7 Î¼M).107 Kim et al. found that the" exact="ethanol" post="extract of Psoralea corylifolia seeds showed strong activity against"/>
  <result pre="Î¼g/mL). Furthermore, they demonstrated that six flavonoids isolated from the" exact="ethanol" post="extract displayed PLpro inhibition in a dose-dependent manner with"/>
  <result pre="vinyl sulfones is associated with the presence of a basic" exact="piperazine" post="ring at the P3 position, which is consistent with"/>
  <result pre="that nitazoxanide inhibited SARS-CoV-2 with an EC50 of 2.12 Î¼M." exact="Nafamostat" post="(49), a highly efficacious inhibitor of MERS-CoV as it"/>
  <result pre="with an EC50 of 22.5 Î¼M. However, the nucleoside analog" exact="penciclovir" post="(50) was required for viral inhibition, yielding an EC50"/>
  <result pre="and pharmacologically active compounds and identified seven compounds (lycorine (8)," exact="mycophenolic acid" post="(61), emetine (62), mycophenolate mofetil (63), phenazopyridine (64), monensin"/>
  <result pre="identified seven compounds (lycorine (8), mycophenolic acid (61), emetine (62)," exact="mycophenolate mofetil" post="(63), phenazopyridine (64), monensin sodium (65), and pyrvinium pamoate"/>
  <result pre="(lycorine (8), mycophenolic acid (61), emetine (62), mycophenolate mofetil (63)," exact="phenazopyridine" post="(64), monensin sodium (65), and pyrvinium pamoate (66)) as"/>
  <result pre="to identify effective anti-SARS agents. The potent inhibitors found were" exact="reserpine" post="(70), a well-known antihypertensive drug derived from several members"/>
  <result pre="equally as important as antivirals. In fact, glucocorticoids such as" exact="methylprednisolone" post="have been approved to treat some severe COVID-19 patients"/>
  <result pre="that a low-to-moderate dose (6 mg/day for 10 days) of" exact="dexamethasone" post="reduced deaths in hospitalized COVID-19 patients who were on"/>
  <result pre="CaoR.; ZhangL.; YangX.; LiuJ.; XuM.; ShiZ.; HuZ.; ZhongW.; XiaoG.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
  <result pre="in vitro. Cell Res.2020, 30, 269â€&quot;271. 10.1038/s41422-020-0282-0.32020029 GaoJ.; TianZ.; YangX.Breakthrough:" exact="Chloroquine" post="phosphate has shown apparent efficacy in treatment of COVID-19"/>
  <result pre="YanY.; ZouZ.; SunY.; LiX.; XuK. F.; WeiY.; JinN.; JiangC.Anti-malaria drug" exact="chloroquine" post="is highly effective in treating avian influenza A H5N1"/>
  <result pre="KeyaertsE.; LiS.; VijgenL.; RysmanE.; VerbeeckJ.; Van RanstM.; MaesP.Antiviral activity of" exact="chloroquine" post="against human coronavirus OC43 infection in newborn mice. Antimicrob."/>
  <result pre="multicenter prospective observational study of the safety and efficacy of" exact="chloroquine" post="for the treatment of COVID-19. medRxiv2020, 10.1101/2020.04.26.20081059. McChesneyE. W.Animal"/>
  <result pre="of COVID-19. medRxiv2020, 10.1101/2020.04.26.20081059. McChesneyE. W.Animal toxicity and pharmacokinetics of" exact="hydroxychloroquine" post="sulfate. Am. J. Med.1983, 75, 11â€&quot;18. 10.1016/0002-9343(83)91265-2.6408923 GautretP.; LagierJ.-C.;"/>
  <result pre="T.; HonorÃ©S.; ColsonP.; ChabriÃ¨reE.; La ScolaB.; RolainJ.-M.; BrouquiP.; RaoultD.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
  <result pre="ChenZ.; HuJ.; ZhangZ.; JiangS.; HanS.; YanD.; ZhuangR.; HuB.; ZhangZ.Efficacy of" exact="hydroxychloroquine" post="in patients with COVID-19: results of a randomized clinical"/>
  <result pre="dissemination of results and its consequences regarding the use of" exact="hydroxychloroquine" post="for COVID-19. Ann. Intern. Med.2020, 172, 819â€&quot;821. 10.7326/M20-1223.32227189 TangW.;"/>
  <result pre="KerneisS.; MÃ©nagerP.; MouthonL.; AudureauE.; RavaudP.; GodeauB.; GallienS.; Costedoat-ChalumeauN.Clinical efficacy of" exact="hydroxychloroquine" post="in patients with Covid-19 pneumonia who require oxygen: observational"/>
  <result pre="McDonaldE. G.; RajasinghamR.; LeeT. C.; HullsiekK. H.A randomized trial of" exact="hydroxychloroquine" post="as postexposure prophylaxis for Covid-19. N. Engl. J. Med.2020,"/>
  <result pre="rapid antiviral clearance or clinical benefit with the combination of" exact="hydroxychloroquine" post="and azithromycin in patients with severe COVID-19 infection. Med."/>
  <result pre="clearance or clinical benefit with the combination of hydroxychloroquine and" exact="azithromycin" post="in patients with severe COVID-19 infection. Med. Mal. Infect.2020,"/>
  <result pre="50, 384â€&quot;387. 10.1016/j.medmal.2020.03.006.32240719 MehraM. R.; DesaiS. S.; RuschitzkaF.; PatelA. N.RETRACTED:" exact="Hydroxychloroquine" post="or chloroquine with or without a macrolide for treatment"/>
  <result pre="10.1016/j.medmal.2020.03.006.32240719 MehraM. R.; DesaiS. S.; RuschitzkaF.; PatelA. N.RETRACTED: Hydroxychloroquine or" exact="chloroquine" post="with or without a macrolide for treatment of COVID-19:"/>
  <result pre="vitro antiviral activity and projection of optimized dosing design of" exact="hydroxychloroquine" post="for the treatment of severe acute respiratory syndrome coronavirus"/>
  <result pre="against novel coronavirus (SARS-CoV-2). Pharmacol. Res.2020, 156, 10476110.1016/j.phrs.2020.104761.32205232 LedfordH.Coronavirus breakthrough:" exact="dexamethasone" post="is first drug shown to save lives. Nature2020, 582,"/>
 </snippets>
</snippetsTree>
